Ovid Therapeutics Inc. (OVID) on Tuesday announced the appointment of Petra Kaufmann as its chief medical officer.
Kaufmann brings extensive experience from both the biopharmaceutical industry and the U.S. National Institutes of Health, where she previously led national rare-disease research initiatives and clinical-trial infrastructure programs.
She joins Ovid from Vigil Neuroscience—recently acquired by Sanofi—where she served as Chief Medical Officer and oversaw medical, clinical, biomarker, patient advocacy, and regulatory functions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.